Cargando…

Open drug discovery for the Zika virus

The Zika virus (ZIKV) outbreak in the Americas has caused global concern that we may be on the brink of a healthcare crisis. The lack of research on ZIKV in the over 60 years that we have known about it has left us with little in the way of starting points for drug discovery. Our response can build...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ekins, Sean, Mietchen, Daniel, Coffee, Megan, Stratton, Thomas P, Freundlich, Joel S, Freitas-Junior, Lucio, Muratov, Eugene, Siqueira-Neto, Jair, Williams, Antony J, Andrade, Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2016
Materias:	Opinion Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841202/ https://www.ncbi.nlm.nih.gov/pubmed/27134728 http://dx.doi.org/10.12688/f1000research.8013.1

Ejemplares similares

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

OpenZika: An IBM World Community Grid Project to Accelerate Zika Virus Drug Discovery
por: Ekins, Sean, et al.
Publicado: (2016)

A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus
por: Ekins, Sean, et al.
Publicado: (2014)

Finding small molecules for the ‘next Ebola’
por: Ekins, Sean, et al.
Publicado: (2015)

Illustrating and homology modeling the proteins of the Zika virus
por: Ekins, Sean, et al.
Publicado: (2016)

Collaboration for rare disease drug discovery research
por: Litterman, Nadia K., et al.
Publicado: (2014)

The A–Z of Zika drug discovery
por: Mottin, Melina, et al.
Publicado: (2018)

Déjà vu: Stimulating open drug discovery for SARS-CoV-2
por: Ekins, Sean, et al.
Publicado: (2020)

The new alchemy: Online networking, data sharing and research activity distribution tools for scientists
por: Williams, Antony J., et al.
Publicado: (2017)

Zika: How safe is India?
por: Doss, C. George Priya, et al.
Publicado: (2017)

The Scientific Response to Zika Virus
por: Martín-Acebes, Miguel A., et al.
Publicado: (2019)

Open Drug Discovery Teams: A Chemistry Mobile App for Collaboration
por: Ekins, Sean, et al.
Publicado: (2012)

Why Open Drug Discovery Needs Four Simple Rules for Licensing Data and Models
por: Williams, Antony J., et al.
Publicado: (2012)

Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets
por: Clark, Alex M., et al.
Publicado: (2015)

Zika is not a reason for missing the Olympic Games in Rio de Janeiro: response to the open letter of Dr Attaran and colleagues to Dr Margaret Chan, Director - General, WHO, on the Zika threat to the Olympic and Paralympic Games
por: Codeço, Claudia, et al.
Publicado: (2016)

Zika vaccines and therapeutics: landscape analysis and challenges ahead
por: Wilder-Smith, Annelies, et al.
Publicado: (2018)

Enhancing Hit Identification in Mycobacterium tuberculosis Drug Discovery Using Validated Dual-Event Bayesian Models
por: Ekins, Sean, et al.
Publicado: (2013)

Zika genomics urgently need standardized and curated reference sequences
por: Theys, Kristof, et al.
Publicado: (2017)

Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease
por: Cechetto, Jonathan, et al.
Publicado: (2011)

Navigating the Zika panic
por: Grubaugh, Nathan D., et al.
Publicado: (2016)

Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal Neuropathy
por: Sames, Lori, et al.
Publicado: (2014)

Threats of Zika virus transmission for Asia and its Hindu-Kush Himalayan region
por: Dhimal, Meghnath, et al.
Publicado: (2018)

Combining Metabolite-Based Pharmacophores with Bayesian Machine Learning Models for Mycobacterium tuberculosis Drug Discovery
por: Ekins, Sean, et al.
Publicado: (2015)

Pathogen Discovery
por: Lipkin, W. Ian
Publicado: (2008)

The global spread of Zika virus: is public and media concern justified in regions currently unaffected?
por: Gyawali, Narayan, et al.
Publicado: (2016)

Causal or not: applying the Bradford Hill aspects of evidence to the association between Zika virus and microcephaly
por: Frank, Christina, et al.
Publicado: (2016)

Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library
por: Pascoalino, Bruno S., et al.
Publicado: (2016)

High Throughput and Computational Repurposing for Neglected Diseases
por: Hernandez, Helen W., et al.
Publicado: (2018)

Looking Back to the Future: Predicting in Vivo Efficacy of Small Molecules versus Mycobacterium tuberculosis
por: Ekins, Sean, et al.
Publicado: (2014)

Creativity and the exceptional aging artist
por: Freundlich, August L, et al.
Publicado: (2006)

Mechanism of Action of Methotrexate Against Zika Virus
por: Beck, Sungjun, et al.
Publicado: (2019)

Zika mosquito vectors: the jury is still out
por: Leal, Walter S.
Publicado: (2016)

Challenges in Drug Discovery for Intracellular Bacteria
por: Tucker, Allison N., et al.
Publicado: (2021)

An Image-Based Algorithm for Precise and Accurate High Throughput Assessment of Drug Activity against the Human Parasite Trypanosoma cruzi
por: Moon, Seunghyun, et al.
Publicado: (2014)

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2018)

Phenotypic Screens, Chemical Genomics, and Antimalarial Lead Discovery
por: Garcia-Bustos, Jose F., et al.
Publicado: (2011)

Optical and chemical discoveries recognized for impact on biology and psychiatry
por: Deisseroth, Karl
Publicado: (2017)

COVID-19: An Update about the Discovery Clinical Trial
por: Vanden Eynde, Jean Jacques
Publicado: (2020)

Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery
por: Ekins, Sean, et al.
Publicado: (2015)

A critical overview of computational approaches employed for COVID-19 drug discovery
por: Muratov, Eugene N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fo0i7lpl20q28e2g4uhfnfhf4t